Human eIF4AIII interacts eIF4G-like partner, NOM1, revealing evolutionarily conserved function
outside exon junction complex
Andrei Alexandrov, David Colognori, Joan  Steitz1
Department Molecular Biophysics Biochemistry, Howard Hughes Medical Institute, Yale University School Medicine,
New Haven, Connecticut 06536, USA



Despite lack exon junction complex (EJC), Saccharomyces cerevisiae contains Fal1p, DEAD-box
helicase highly homologous eIF4AIII. yeast Fal1p functionally orthologous human eIF4AIII, expression human eIF4AIII complements lethal phenotype 18S rRNA biogenesis defect fal1D(null) yeast. yeast Fal1p interacts genetically eIF4G-like protein, Sgd1p: allele sgd1 acts dominant extragenic suppressor mutation predicted RNA-binding residue Fal1p, synthetically exacerbates growth defect fal1 mutation. sgd1 mutations map single, short, evolutionarily conserved patch matches key eIF4A-interacting residues eIF4G superimposed X-ray structure eIF4A/eIF4G complex. demonstrate direct physical interactions yeast Sgd1p Fal1p, human orthologs (NOM1 eIF4AIII) vitro vivo,
identifying human NOM1 missing eIF4G-like interacting partner eIF4AIII. Knockdown eIF4AIII NOM1 human cells demonstrates novel conserved eIF4A/eIF4G-like complex acts pre-rRNA
processing, adding established functions eIF4A/eIF4G translation initiation eIF4AIII core
component EJC.
[Keywords: eIF3AIII; NOM1; FAL1; SGD1; exon junction complex; ribosome biogenesis]
Supplemental material available article.
Received July 20, 2010; revised version accepted March 28, 2011.




RNA helicases ubiquitously present organisms                         functions, substrates, relevant interacting partners ranging viruses humans. Helicases participate                       RNA helicases known cases (Bleichert numerous aspects RNA metabolism, including                            Baserga 2007). DEAD-box subfamily largest
transcription, editing, mRNA splicing, 39-end formation,                    group RNA helicases, displaying considerable sequence
export, mRNA translation initiation termination,                        homology, including conservation helicase motifs quality control, degradation, ribosome biogenesis                       helicase core (Tanner Linder 2001).  DEAD-
(Rocak Linder 2004). Known molecular functions                          box helicases specific: able com- RNA helicases include unwinding RNA duplexes                          plement deletion DEAD-box helicase (Ray et al. 1985), removal mRNP protein components                       overexpressed (Tanner et al. 2003).
(Fairman et al. 2004), serving RNA clamps (Ballut et al.                    translation initiation factor eIF4A (encoded 2005), annealing RNA strands (Yang Jankowsky 2005),                     eIF4AI eIF4AII) best studied DEAD-box stabilizing RNA folding intermediates (Solem et al.                     helicases. eIF4A considered ‘‘minimal’’ DEAD-box
2006). functions, energy NTP                       helicase core eIF4A-like domain lacks N-termi-
hydrolysis strictly required.  like serving                nal C-terminal extensions (Tanner Linder 2001).
RNA clamps placeholders, ATP hydrolysis appears                    eIF4A functions cap-dependent translation initiation
dispensable (Ballut et al. 2005; Shibuya et al. 2006). Despite              required melt secondary structure variety (Saccharomyces cerevisiae, example,                   59 untranslated region (UTR) allow scanning mRNA
39 putative helicases) essential roles, exact                 recognition start codon. hetero-
                                                                            trimeric complex eIF4F (eIF4G, eIF4A, eIF4E) (Rozen
1
                                                                            et al. 1990), eIF4G central scaffolding protein
 Corresponding author.
E-MAIL joan.steitz@yale.edu; FAX (203) 624-8213.                            binds m7Gppp cap-binding protein eIF4E Article online http://www.genesdev.org/cgi/doi/10.1101/gad.2045411.   recruits 43S preinitiation complex (consisting 

1078       GENES & DEVELOPMENT 25:1078–1090 Ó 2011 Cold Spring Harbor Laboratory Press ISSN 0890-9369/11; www.genesdev.org
                                                                                        eIF4AIII eIF4G-like partner, NOM1



40S ribosomal subunit initiation factors eIF1, eIF1A,      vitro, demonstrated coprecipitation endogenous
eIF2, eIF3, eIF5, Met-tRNAIni) eIF3 subunit        eIF4AIII Flag-tagged NOM1 nuclear extracts (Hinnebusch 2006).                                             human cells GST pull-downs heterologously ex-
   DEAD-box helicase eIF4AIII striking homol-          pressed purified proteins. Consistent conservation
ogy eIF4A, functionally distinct:     function complex yeast humans, known role translation initiation, localized   knockdown eIF4AIII NOM1 affects pre-rRNA nucleus, does substitute eIF4A     processing site 1 human cells, knockdown vitro ribosome-binding assays, inhibits translation     eIF4AIII additionally affects pre-rRNA processing site 2.
vitro (Li et al. 1999). Human eIF4AIII reported        depending interacting partners, human bind eIF4G vitro (Li et al. 1999), functional     eIF4AIII plays dual role central biogenesis
consequences association described.          pathways cells: leading rRNA mRNA.
Instead, eIF4AIII plays central role coupling mRNA
splicing downstream events core component exon junction complex (EJC). multiprotein complex         Results deposited mRNA splicing ;25 nucleo-
                                                               Human eIF4AIII specifically complements lethal
tides (Le Hir et al. 2000a) upstream exon–exon
                                                               phenotype restores 18S rRNA levels
junction (Le Hir et al. 2000b). EJC binds mRNA                                                                fal1D yeast cells
sequence-independent manner high affin-
ity; certain components EJC stably associate       S. cerevisiae Fal1p highly homologous meta-
mRNA nuclear export later cyto-         zoan eIF4AIII (Fig. 1A), used plasmid shuffle (Supple-
plasm. EJC plays key role nonsense-mediated           mental Fig. S1A) ask eIF4AIII humans
mRNA decay (NMD) (Le Hir et al. 2001; Lykke-Andersen           D. melanogaster complement lethal phenotype
et al. 2001), mRNA localization (Palacios et al. 2004),        yeast Fal1p deletion (Fig. 1B). observed complemen-
mRNA export nucleus (Le Hir et al. 2001),         tation specific eIF4AIII, yeast human enhancing effect splicing translation (Nott et al.   DEAD-box helicases tested (human eIF4AI, human
2004). crystal structure EJC core proteins com-     eIF4AII, yeast eIF4A [Tif1p]) complement (Fig.
plexed RNA revealed eIF4AIII’s RecA-like              1B). Expression analysis Protein tagged proteins
domains enclosing ATP molecule, Magoh/Y14              demonstrated lack complementation MLN51 stabilizing eIF4AIII ATP-bound             lower protein expression (Supplemental Fig. S1B),
RNA-locked state (Andersen et al. 2006; Bono et al. 2006).     levels noncomplementing proteins (human
   Surprisingly, eIF4AIII-like proteins comprise separate    eIF4AI eIF4AII yeast Tif1p) eIF4AIII mu-
branch evolutionary tree (Li et al. 1999; Linder        tants (K88N E188Q) higher similar 2003), >60  sequence identity entire           human eIF4AIII(WT).
length humans yeast (Fig. 1A). odds           confirm observed complementation, used conservation reports EJC components           promoter shutoff approach (Fig. 1C; Supplemental Fig.
Drosophila melanogaster Caenorhabditis elegans         S1C). fal1D strains expressing human eIF4AIII required NMD (Gatfield et al. 2003; Palacios et al.    GAL1 promoter (fal1D pPGAL1H.eIF4AIII) viable 2004; Longman et al. 2007), S. cerevisiae lacks        grown galactose, glucose (vector Fig. 1C). known EJC components NMD yeast does           Introduction additional plasmid expressing human
depend splicing (Gonzalez et al. 2001). Instead, S.     eIF4AIII GST fusion PCUP1 promoter (Cu2+-
cerevisiae eIF4AIII-like protein Fal1p essential 18S    responsive; expression increased Cu2+ present)
rRNA biogenesis, specifically 35S pre-rRNA process-        rescued growth fal1D pPGAL1H.eIF4AIII strain ing sites A0, A1, A2 (Kressler et al. 1997).            glucose (H.eIF4AIII Fig. 1C). Rescue depended Cu2+
    using genetic screen dominant allele-spe-       concentration medium, double mutations
cific extragenic suppressors fal1 cold-sensitive (CS)   K88A, T89P (Walker box) D187E, E188L (Walker B
phenotype, identified essential S. cerevisiae com-       box) human eIF4AIII completely abolished comple-
plex, Fal1p/Sgd1p, homologous eIF4A/eIF4G          mentation. Notably, eIF4AIII D. melanogaster acts outside translation initiation. Instead,     complemented fal1D dependent Cu2+, weakly
required 18S rRNA biogenesis. mutation          human protein.
Fal1p affected growth pre-rRNA processing sites            test function, asked human eIF4AIII A0, A1, A2, suppressing mutation Sgd1p allevi-        rescue 18S rRNA biogenesis defect reported pre-
ated growth pre-rRNA processing defects.          viously fal1 temperature-sensitive (TS) strain (Fig. demonstrated human eIF4AIII,             2A; Kressler et al. 1997).  expression human
highly homologous yeast Fal1p, functional         eIF4AIII GAL1 promoter galactose  ortholog Fal1p, heterologous expression hu-        glucose) restored growth fal1D(null) strain liquid
man eIF4AIII yeast specifically complemented growth         culture (Fig. 2B,C). 18S rRNA levels restored near rRNA biogenesis defects FAL1 deletion. Consis-          normal (Fig. 2D, panel), levels 20S rRNA, tent evolutionary conservation Fal1p/Sgd1p         18S precursor, partially restored (Fig. 2D, middle
complex, human NOM1, homologous yeast              panel) accumulation 23S rRNA partially
Sgd1p, interacts directly eIF4AIII vivo         relieved (Fig. 2D, panel).  results


                                                                                           GENES & DEVELOPMENT            1079
 Alexandrov et al.




Figure 1. Human eIF4AIII homologous replace S. cerevisiae Fal1p vivo.   Amino acid sequence alignment eIF4AIII
homologous proteins humans, Mus musculus, Xenopus laevis, D. melanogaster, C. elegans, S. cerevisiae. Walker B
boxes shown gray rectangles. sequence D. melanogaster VASA  indicated amino acids Walker boxes human eIF4AIII, mutations (K88N E188Q) reported previously (Shibuya et al. 2006; Zhang                                                                                                 •
Krainer 2007) abolish ATPase activity vitro, NMD vivo EJC assembly vitro ( ), conserved threonine (T322), mutation valine S. cerevisiae Fal1p resulted CS phenotype (m). (B) Expression human D. melanogaster eIF4AIII
complements lethal phenotype yeast fal1D, observed plasmid shuffle (Supplemental Fig. S1A); Walker B boxes required complementation. (H.eIF4AIII) human eIF4AIII; [H.eIF4AIII(K88N) H.eIF4AIII(E188Q)] Walker B box mutants human eIF4AIII; (D.eIF4AIII) D. melanogaster eIF4AIII; (Fal1) S. cerevisiae Fal1p; (H.eIF4AI H.eIF4AII) human eIF4AI eIF4AII.
(C) Expression human D. melanogaster eIF4AIII complements lethal phenotype yeast fal1D, observed GAL1
promoter shutoff activation expression copper-inducible promoter (CUP1) increasing concentrations Cu2+
(Supplemental Fig. S1C). (H.eIF4AIII) human eIF4AIII; (KT/AP) K88T, A89P;  EL) D188E, E189L; (D.eIF4AIII) D. melanogaster
eIF4AIII; (Fal1)S. cerevisiae Fal1p.




1080       GENES & DEVELOPMENT
                                                                                                   eIF4AIII eIF4G-like partner, NOM1




Figure 2. Expression human eIF4AIII restores 18S rRNA biogenesis S. cerevisiae fal1D strain.   Schematic rRNA
processing S. cerevisiae. (B) Depletion Fal1p yeast S. cerevisiae results growth defect liquid culture. (C) Expression human eIF4AIII GAL1 promoter rescues growth defect yeast fal1D strain liquid culture. (D, panel) Expression human eIF4AIII restores 18S rRNA levels yeast fal1D strain (probes L2 L9). (Middle panel) Expression human eIF4AIII
partially restores 20S rRNA levels yeast fal1D strain (probe L3).  panel) Expression human eIF4AIII partially relieves
accumulation 23S rRNA yeast fal1D strain (probe L1). Supplemental Figure S2 shows probes.


demonstrate human eIF4AIII substitute Fal1p                sgd1(S340Y) dominant extragenic suppressor function 18S ribosome biogenesis yeast.                       T322V mutation putative RNA-binding
                                                                        domain Fal1p
Mutations conserved Walker B boxes
                                                                        Fal1p considered ‘‘minimal’’ helicase human eIF4AIII abolish rescue fal1D
                                                                        contains RecA domains extensions
yeast phenotype
                                                                        (Kressler et al. 1997). suggests factor(s) amino acid sequences Walker B boxes                 responsible substrate specificity. iden-
human eIF4AIII completely conserved yeast                   tify factor(s)  possibly, substrates Fal1p, humans (Fig. 1A).  human eIF4AIII bearing K88N                  attempted tandem affinity purification (TAP) approach
E188Q single mutations Walker B boxes,                     successful, probably transient
respectively, lacking detectable ATPase activity,              nature interactions. focused genetic surprisingly support NMD vivo assemble                    screens, aiming identify spontaneous extragenic domi-
EJC vitro (Shibuya et al. 2006).  non-                  nant allele-specific suppressors mutations conserved
hydrolyzable ATP analog AMP-PNP substitute                      RNA-interacting amino acids Fal1p (Supplemental Fig.
ATP EJC core assembly vitro (Ballut et al. 2005;              S8A,B). advantage interacting partners (suppres-
Andersen et al. 2006; Bono et al. 2006), confirming                sors) identified physical interaction required ATPase activity eIF4AIII required               cell survival, regardless weak transient functions human eIF4AIII bearing K88A muta-                     contact  Based results genetic screens
tion Walker box active Y14/Magoh                     (Supplemental Figs. S8–S10), constructed yeast strains
loading complementation assay despite lack heli-                 carrying individual chromosomal sgd1(S340Y) case activity (Zhang Krainer 2007).                                 sgd1(N343Y) mutations fal1(T322V) background
   conservation Walker B boxes                     [abbreviated fal1(T/V)]. Growth curves (Fig. 3A)
Fal1p orthologs nonetheless striking, tested                  serial dilutions (Fig. 3B; Supplemental Fig. S3A) K88N E188Q mutations human eIF4AIII com-                     yeast strains demonstrate sgd1(S340Y) acts plementation yeast fal1D lethal phenotype. Figure                dominant (Supplemental Fig. S3A, cf. lanes 3,4 5,6)
1B shows mutations completely abolish rescue,                extragenic suppressor fal1(T/V) CS growth phenotype
highlighting crucial role conserved Walker B             (Fig. 3B, cf. lanes 2 3 16°C).
boxes function human eIF4AIII shared                  lines evidence demonstrate allele specificity
Fal1p heterologous                                       suppression fal1(T/V) CS phenotype 

                                                                                                      GENES & DEVELOPMENT            1081
 Alexandrov et al.



                                                                                  Figure 3. SGD1 interacts genetically                                                                                   FAL1.   Extragenic suppressor sgd1(S340Y)
                                                                                  alleviates growth defect CS
                                                                                  fal1(T322V) strain liquid culture (YPD)
                                                                                  (strains exponentially grown 30°C
                                                                                  shifted 16°C time 0). (B)                                                                                   sgd1(S340Y) suppresses growth defect
                                                                                  fal1(T322V) strain 16°C, nearby
                                                                                  mutation [sgd1(N343Y)] protein
                                                                                  results growth defect synthetic                                                                                   fal1(T322V) 37°C (YPD).




sgd1(S340Y).  phenotype different fal1(Q144R,    partner Fal1p, 60  identical eIF4A
V167T, A194V, M221T, D223G, C272G, A372T, P390T)                (Fig. 1A; Kressler et al. 1997).
mutant strain TS (Supplemental Fig. S3D,E)             lines evidence suggested potential suppressed tested temperature sgd1(S340Y),        physical eIF4G/eIF4A-like interaction Sgd1p sgd1(N343Y), SGD1(WT) expressed multicopy              Fal1p yeast, NOM1 eIF4AIII  single copy (Supplemental Fig. S3B,C). Second,          respective orthologs) humans.  dominant allele-
SGD1(WT), sgd1(S340Y), sgd1(N343Y) suppressed           specific suppressor mutation, sgd1(S340Y), syn-
lethal fal1D(null) phenotype, demonstrated plasmid        thetic mutation sgd1(N343Y) appeared MIF4G  shuffle (Supplemental Fig. S4A,B).            major eIF4A-interacting) domain Sgd1p (Fig. 4A). Second,
chromosomal sgd1(S340Y) mutation suppressed                 MIF4G domain itself, mutations
fal1(T/V) CS phenotype (Fig. 3B, cf. lanes 2 3           remarkably appeared amino acids apart 12-
16°C), nearby sgd1(N343Y) mutation little          amino-acid conserved motif (NSSLNKLSDSNI yeast
effect growth fal1(T/V) strain temper-    Sgd1p KSLLNKLTLEMF yeast eIF4G [Tif1p]) (Fig.
ature (Fig. 3B, cf. lanes 2 5 16°C). Instead,        4A), representing major surface eIF4G contacts
sgd1(N343Y) fal1(T/V) double mutant displayed syn-            eIF4A (Schutz et al. 2008).  S612 N615 thetic growth defect elevated temperatures (Fig. 3B,         yeast eIF4G (corresponding S340 N343 yeast
cf. lanes 2, 5, 6 37°C); complementation          Sgd1p) form direct intermolecular hydrogen bonds
synthetic growth defect sgd1(N343Y) fal1(T/V)            eIF4A, based X-ray structure yeast
double mutant plasmid-expressed SGD1 FAL1             eIF4A/eIF4G complex (Fig. 4B; Schutz et al. 2008). 
shown Supplemental Figure S4C (cf. lanes 2,5,6 Fig.       human NOM1 shown previously interact 3B lanes 2–4 Supplemental Fig. S4C).                     eIF4A yeast hybrid screens pull assays
                                                                (Simmons et al. 2005); vitro interaction GST-
                                                                tagged NOM1 eIF4AIII mentioned ‘‘data Genetically interacting residues Sgd1p (S340
                                                                shown’’ (Simmons et al. 2005). N343) identify conserved interface                                                                     present lines evidence conserved
yeast Sgd1p/Fal1p human NOM1/eIF4AIII
                                                                direct eIF4G/eIF4A-like physical interaction existence dominant allele-specific suppressor          Sgd1p Fal1p yeast, NOM1 eIF4AIII reflects functional physical interaction        humans:  TAP-Fal1p Myc-Sgd1p specifically proteins. Sgd1p highly conserved (Fig. 4A)        coimmunoprecipitate extracts formaldehyde
known essential S. cerevisiae (Akhtar et al. 2000),    cross-linked yeast cells (Fig. 5A; Supplemental Fig. S6A).
D. melanogaster (http://www.flybase.org), C. elegans        Second, comparable specific interaction exists (Maeda et al. 2001); Sgd1p homologs            human counterparts: Myc-eIF4AIII Flag-NOM1
majority sequenced eukaryotes (Supplemental Fig. S5),        coimmunoprecipitate nuclear extracts human
including human. Sgd1p eIF4G-like protein (Ponting        HEK293 cells (Fig. 5B), cross-linking required.
2000; Marintchev Wagner 2005) containing MIF4G               direct interaction human eIF4AIII MA3 domains (Fig. 4A). MIF4G MA3                   NOM1 reconstituted using heterologously ex-
domains eIF4G shown previously bind eIF4A            pressed purified proteins (Fig. 5D). Finally, identified
(Morino et al. 2000; Oberer et al. 2005; Schutz et al. 2008).   endogenous human eIF4AIII 24 proteins specifi- plausible MIF4G-containing Sgd1p        cally copurifying nuclear extract human HEK293


1082       GENES & DEVELOPMENT
                                                                                                  eIF4AIII eIF4G-like partner, NOM1




Figure 4. suppressor mutation sgd1(S340Y) synthetic mutation sgd1(N343Y) map known conserved 12-amino-acid motif comprises largest interface eIF4G eIF4A.   Amino acid sequence alignment S. cerevisiae protein Sgd1p putative Sgd1p-like proteins humans, M. musculus, D. melanogaster, C. elegans. Predicted MIF4G MA3 domains (Ponting
2000) indicated blue purple boxes, respectively. conserved 12-amino-acid motif (KSLLNKLTLEMF yeast eIF4G NSSLNKLSDSNI yeast Sgd1p), representing largest surface eIF4G interacting eIF4A (Schutz et al. 2008), indicated red box. Mutations Sgd1p result genetic interactions fal1(T/V) indicated triangles; residues known form intermolecular hydrogen bonds eIF4A, based crystal structure eIF4G/eIF4A complex (Schutz et al.
2008). (B) Structure eIF4G/eIF4A complex (Schutz et al. 2008) showing locations residues homologous starting
mutation Fal1p (eIF4A) suppressor synthetic mutations Sgd1p (eIF4G). major eIF4A/eIF4G interaction interface marked red oval.




                                                                                                     GENES & DEVELOPMENT            1083
 Alexandrov et al.



                                                                                              Figure 5. Direct physical interactions 
                                                                                              tween S. cerevisiae Fal1p Sgd1p                                                                                               human eIF4AIII NOM1.  
                                                                                              Yeast Sgd1p Fal1p coimmunoprecipi-
                                                                                              tate. Western blot IgG precipitates                                                                                               extracts formaldehyde cross-linked yeast
                                                                                              cells expressing tagged untagged ver-
                                                                                              sions yeast Sgd1p Fal1p (Supplemen-
                                                                                              tal Fig. S6A), indicated. proteins                                                                                               expressed promoters. TAP-
                                                                                              tagged yeast protein (Trm8p) known
                                                                                              nuclear localization provided negative 
                                                                                              trol. TAP-tagged proteins precipitated
                                                                                              using bead-immobilized rabbit IgG  ZZ
                                                                                              domain Staphylococcus aureus protein                                                                                               present TAP tag binds IgG) (Rigaut
                                                                                              et al. 1999). noncovalent complex                                                                                               horseradish peroxidase (HRP) poly-
                                                                                              clonal rabbit anti-peroxidase (PAP) used
                                                                                              Western blot detection TAP-tagged
                                                                                              proteins (Puig et al. 2001)  ZZ domain
                                                                                              protein TAP tag binds PAP);
                                                                                              detection c-myc epitope used HRP-
                                                                                              conjugated mouse monoclonal antibody 9E10.
                                                                                              (B) Human eIF4AIII NOM1 coimmuno-
                                                                                              precipitate. Western blot Flag-purified sam-
                                                                                              ples nuclear extract human HEK293
                                                                                              cells expressing transiently transfected tagged untagged versions human eIF4AIII NOM1, indicated  cross-linking required). Flag-tagged human protein METTL1, known nuclear localization provided negative control. (C) Endogenous human eIF4AIII identified mass spectrometry 24
protein bands specifically copurifying nuclear extract human HEK293 cells Flag-tagged NOM1 (silver staining) (Supplemental
Fig. S6B). (D) Direct interaction heterologously expressed purified human GST-eIF4AIII NOM1 demonstrated GST pull-  gel Coomassie-stained). arrow shows position length NOM1 copurified GST-eIF4AIII. GST-tagged purified
yeast protein Trm82p provided negative control. (Lane 8) Additional bands NOM1 preparation represent N terminally truncated
forms NOM1. I1 I2 denote inputs pull-downs shown lanes 1 2, lanes 3 4, respectively.



cells Flag-tagged NOM1 (Fig. 5C; Supplemental Fig.                  levels, partially alleviates increases 35S pri-
S6B) using mass spectrometry.                                            mary transcript (Fig. 6A, middle panels)                                                                          23S rRNA (Fig. 6A, middle panels). 
Sgd1p/Fal1p NOM1/eIF4AIII form functional
                                                                         consistent Fal1p Sgd1p acting 18S
complexes acting 18S rRNA biogenesis
                                                                         rRNA biogenesis, depletion Sgd1p results pre-rRNA S. cerevisiae humans, respectively
                                                                         processing defects identical Fal1p: Slow
Sgd1p NOM1 documented nucleolar proteins                      growth (Supplemental Fig. S7B,C) yeast strain (Sup- yeast humans (Akhtar et al. 2000; Simmons                       plemental Fig. S7A) expressing Sgd1p GAL1 pro-
et al. 2005); function Sgd1p yeast rRNA biogenesis              moter medium containing glucose accompanied reported (Li et al. 2009). demonstrated                 drastic decreases 18S (Fig. 6B, panel; Supple- genetic physical interactions observed                     mental Fig. S7D) 20S (Fig. 6B, panel) rRNA
tween Sgd1p Fal1p correlate collaborative                 levels, accumulation 23S rRNA (Fig. 6B, middle
function 18S rRNA biogenesis.  showed                   panels) 35S rRNA primary transcript CS yeast strain fal1(T/V) displays pre-rRNA process-                 (Fig. 6B, middle panels).
ing defects sites A0, A1, A2, resulting decrease                Furthermore, consistent evolutionary conserva- 18S  18S/25S ratio fal1(T/V) strain 75               tion function Sgd1p/Fal1p complex wild-type strain] (Fig. 6A, panel) 20S               yeast humans, siRNA-mediated knockdown eIF4AIII
(Fig. 6A, panel) rRNA levels, accumu-                  NOM1 (Supplemental Fig. S11) resulted decreased
lation 23S rRNA (Fig. 6A, middle panels)                   rate 18S rRNA formation HEK293T cells. 35S rRNA primary transcript (Fig. 6A, middle                     vivo pulse-labeled cells 3H-methyl-methionine fol- panels). Second, observed suppressor                  lowed chase cold methionine, observed lower
mutation sgd1(S340Y) rescues rRNA biogen-                    amounts 18S rRNA (Fig. 7B,C, cf. lanes 1–5 7–11).
esis defects fal1(T/V): partially restores mature 18S              decreased 41S pre-rRNA 15 30 min rRNA  18S/25S ratio suppressor strain fal1(T/V)               chase (Fig. 7B,C, cf. amounts 41S pre-rRNA lanes
sgd1(S/Y) 85  wild-type strain] (Fig. 6A,              2,3 8,9) 21S pre-rRNA (Fig. 7B,C, small panel) 20S (Fig. 6A, panel) pre-rRNA                      panels, cf. amounts 21S pre-rRNA lanes 1–5 

1084       GENES & DEVELOPMENT
                                                                                               eIF4AIII eIF4G-like partner, NOM1



7–11); formation 41S 21S pre rRNA (Fig. 7A)
requires cleavage site 1, creates 59 end mature 18S rRNA. decrease ratio newly
synthesized (3H-labeled) mature small-subunit (18S)
rRNA large-subunit (28S) rRNA  observed 3 h chase) seen NOM1 knockdown
cells (Fig. 7C, cf. 18S/28S ratio lanes 6 12). processing delay site 2 observed eIF4AIII
knockdown cells, judged increased ratio unprocessed 45S pre-rRNA 30S/32S pre-rRNA hour chase (Fig. 7B, cf. ratio lanes 4,5 10,11). confirm specificity siRNAs used knockdowns, cotransfected knockdown cells 



                                                                   Figure 7. siRNA-mediated knockdown eIF4AIII                                                                    NOM1 results 18S rRNA biogenesis defect human cells.
                                                                     Schematic rRNA processing humans. (B) siRNA-
Figure 6. extragenic suppressor mutation sgd1(S340Y)           mediated knockdown eIF4AIII results decreased rate alleviates 18S rRNA biogenesis defects CS fal1(T322V)       18S rRNA formation, determined vivo pulse-labeling strain; SGD1 required rRNA processing sites     HEK293T cells [methyl-3H] -methionine followed chase
(A0, A1, A2) FAL1.   18S rRNA biogenesis defect    cold methionine. (Middle panel) Processing 45S S. cerevisiae CS strain fal1(T322V) suppression     formation 41S, 30S/32S, 21S pre-RNAs delayed,
sgd1(S340Y) visualized Northern blot using DNA oligo-       resulting decrease mature 18S rRNA, suggesting defects
nucleotide probes L2 L9  panel), L1 (middle panel),    sites 1 2. (Right panel) Cotransfection plasmid ex-
L3  panel); probes shown Supplemental Figure S2.     pressing siRNA-resistant version eIF4AIII partially rescues
Total RNA prepared strains grown Figure 3A. (B)     rate formation 18S rRNA precursors, confirming
SGD1 required 18S rRNA biogenesis sites A0, A1,      specificity. (C) siRNA-mediated knockdown NOM1 results A2  sites Fal1p). Depletion PGAL1-expressed Sgd1p    decreased rate 18S rRNA formation, determined pulse-
glucose-containing media 16°C results decrease 18S      chase performed B. (Middle panel) Formation 41S 21S
rRNA levels  panel), increase 23S rRNA levels (middle    pre-RNAs delayed, resulting decrease mature 18S rRNA,
panel), decrease 20S rRNA levels  panel),          suggesting processing defect site 1. Consistently, decreased
accumulation 35S rRNA primary transcript (middle        ratio mature small (18S) large (28S) subunit rRNA ob- panels) yeast sgd1D strain (Northern blot        served 3 h chase (cf. lanes 6 12). (Right panel) 
probed  schematics strains shown Supple-     transfection plasmid expressing siRNA-resistant variant
mental Fig. S7A, growth curves shown Supplemental       NOM1 partially rescues rate appearance 18S rRNA Fig. S7B). Arrows left indicate changes levels    21S 41S precursors.
rRNAs intermediates fal1(T/V)   sgd1D (B) strains
compared wild type.


                                                                                                  GENES & DEVELOPMENT            1085
 Alexandrov et al.



plasmids expressing siRNA-resistant eIF4AIII (peIF4AIIIr)       complementation fal1D phenotype (Fig. 7B, right panel) NOM1 (pNOM1r) (Fig. 7C, right        human eIF4AIII requires intact Walker B boxes,
panel), resulted alleviation ob-        identifying function eIF4AIII strictly
served processing defects, vector (Fig. 7B,C,       depends ATP hydrolysis  eIF4AIII middle panels).                                                 expressed heterologously S. cerevisiae).                                                                 known functions eIF4AIII—EJC formation, NMD acti-
                                                                vation, binding GPx1 SECIS element Discussion                                                      abolished mutations despite loss ATPase
                                                                consequent helicase activity vitro (Shibuya et al. identified eIF4G-like human protein NOM1            2006; Zhang Krainer 2007; Budiman et al. 2009).
conserved interacting partner eIF4A-like protein         Finally, showed conservation function eIF4AIII. interaction yeast S. cerevisiae (Fal1p/   Fal1p/Sgd1p complex 18S rRNA biogenesis yeast
Sgd1p) humans (eIF4AIII/NOM1) similar             humans demonstrating pre-rRNA processing 
established eIF4A/eIF4G interaction eIF4F. yeast,     fects arising siRNA-mediated knockdown eIF4AIII partner proteins essential required   NOM1 HEK293T cells. Interestingly, 18S rRNA biogenesis. addition physical       knockdown eIF4AIII NOM1 similarly resulted
teraction involvement steps 18S rRNA         decreased rates formation mature 18S rRNA
biogenesis, established Fal1p Sgd1p ge-         similar processing defect site 1 (formation 41S
netically functionally tied dominant compensa-        21S), delayed processing 45S pre-rRNA site 2
tory suppressor relationship: mutation T322V          specific eIF4AIII knockdown) reflect RNA-interacting residue Fal1p results cold sensi-      specific requirement eIF4AIII NOM1 site 2.
tivity defect yeast 18S rRNA biogenesis,           Alternatively, factor substitute NOM1 dominant allele-specific extragenic suppressor mutation         processing site 2  site 1) following NOM1
S340Y Sgd1p alleviates defects. suppressor         regulation,  possibly, degree NOM1 knock-
mutation large protein Sgd1p (899 amino acids)           sufficient observe defect site 2
spontaneously appeared MIF4G domain  major           processing.
eIF4A-interacting domain eIF4G) 12-amino-acid          versatility displayed eIF4AIII interacting
conserved motif eIF4G NOM1 orthologous             different sets partners beginning proteins represents ‘ largest contiguous interaction   appreciated feature DEAD-box helicases. Mam-
surface’’ eIF4G eIF4A (Schutz et al. 2008).     malian eIF4AIII interacts hand Magoh identified SGD1 mutations interact genetically         Y14, core protein deposits EJC newly FAL1 (extragenic suppressor mutation S340Y             spliced mRNAs nucleoplasm, hand
synthetic mutation N343Y) replace conserved Sgd1p               NOM1 nucleolus. distinct 
amino acids previously shown yeast eIF4G          sociations dictated simply dual subcellular
(S612 N615) form direct intermolecular          localization clear. Interestingly, eIF4AIII hydrogen bonds eIF4A, based X-ray structure         reported reside nucleoli plants (Pendle et al. yeast eIF4A/eIF4G complex (Schutz et al. 2008).          2005), human eIF4AIII mutants surprisingly
   results illuminate novel function       localize nucleolus nucleoplasm
evolutionary origin eIF4AIII protein. Previously         (Shibuya et al. 2006). DEAD-box helicases reported functions eIF4AIII EJC, NMD, neuronal        implicated cellular process protein expression, selenocysteine regulation (Giorgi       Prp43 splicing rRNA processing (Lebaron et al.
et al. 2007; Isken Maquat 2008; Budiman et al. 2009)        2005), eIF4A translation initiation regulation sufficient explain high degree conser-       SMAD degradation D. melanogaster (Li Li 2006),
vation eIF4AIII family (60  identity             Dbp5 mRNA export translation termi-
human eIF4AIII yeast Fal1p entire protein          nation (Gross et al. 2007). lack requirement length) Walker B boxes proteins.         ATP hydrolysis release eIF4AIII  EJC) (1) EJC identified yeast        mRNA substrates ascribed power (Tange et al. 2004), (2) function eIF4AIII NMD     ribosome progressing mRNA trans- conserved D. melanogaster C. elegans (Palacios       lation; rRNA biogenesis, ATP hydrolysis presumably
et al. 2004; Longman et al. 2007), (3) components     leads release eIF4AIII rRNA substrate, EJC conserved metazoans (Tange et al.        allowing progression step processing
2004).                                                          pathway. interesting learn RNA
   uncovered conserved ability human D.           helicases differential requirements ATP
melanogaster eIF4AIII function 18S rRNA biogen-           hydrolysis performing multiple cellular roles.
esis heterologous expression proteins          results consistent idea eIF4G
S. cerevisiae strain lacking essential yeast DEAD-box       NOM1 evolved common ancestor protein
helicase Fal1p. Restoration strain viability        (Marintchev Wagner 2005). eIF4G functions
18S rRNA biogenesis specific,           eIF4AI/II translation initiation eukaryotes, closely related human eIF4AI eIF4AII yeast Tif1         human eIF4G-like protein NOM1 evolved cooperate
proteins did complement fal1D. showed            similar protein, eIF4AIII, completely


1086       GENES & DEVELOPMENT
                                                                                         eIF4AIII eIF4G-like partner, NOM1



different process: 18S rRNA biogenesis. possible    DEAD-box helicases eIF4A family (Tanner
additional partners DEAD-box helicases          Linder 2001). crystal structures EJC
exhibit interactions similar eIF4AIII/NOM1          core (Andersen et al. 2006; Bono et al. 2006) VASA
Fal1p/Sgd1p pairs identified future.            complexed RNA (Sengoku et al. 2006), threo-
   retrospect, initial lack success identifying   forms hydrogen bonds RNA backbone phos-
Sgd1p Fal1p-interacting protein using TAP purifica-       phates. T546A mutation VASA (corresponding tion Fal1p surprising. Instead, highlights    T322 Fal1p) abolishes vitro ATPase helicase
similarity Fal1p/Sgd1p interaction relatively    activities VASA, results 50  decrease cross-
weak, functionally crucial, interaction eIF4A      linking efficiency U10 oligomer (Sengoku et al.
eIF4G eIF4F. Specifically, eIF4A readily         2006). eIF4A/eIF4G interaction model suggests dissociated mammalian eIF4G ion exchange               suppressing (S340) synthetically interacting (N343)
columns (Ray et al. 1985; Etchison Milburn 1987)       residues Sgd1p contact Fal1p opposite exchange free eIF4A (Yoder-Hill et al. 1993).         putative RNA-binding domain (Fig. 4B). possibility Binding eIF4A eIF4G weaker eIF4E         mutations Sgd1p (S340Y N343Y) eIF4G (Gingras et al. 1999). Purified eIF4F complexes       acts direct interaction Fal1p Sgd1p/ plant (Lax et al. 1985), D. melanogaster (Sierra      Fal1p interface induce slight conformational change Zapata 1994), yeast (Goyer et al. 1989) lack eIF4A,    Fal1p(T322V) increases function lower tempera-
presumably eIF4A dissociates isolation.         ture. Mechanistically, suppression conforma-  switched identifying Sgd1p/Fal1p-            tional change RNA-binding region Fal1p induced
associated components using vivo formaldehyde cross-        Sgd1p binding opposite Fal1p linking followed affinity selection using TAP-tagged        consistent model (Oberer et al. 2005) eIF4G
Sgd1p  yeast) Flag-tagged NOM1  cross-          serving soft clamp stabilize relative orientation
linking, human cells). Mass-spectrometric analysis       helicase domains favoring closed
proteins copurifying NOM1-Flag human cell            ‘‘active’’ conformation eIF4A. mechanism nuclear extract identified 24 proteins, 18        consistent numerous reports stimula-
known ribosomal proteins  small 13 large sub-         tion eIF4A helicase activity eIF4G binding
units) (Supplemental Fig. S6B). presence           (Marintchev Wagner 2004). Alternatively, possible
r proteins NOM1 preparations indicate associ-        genetically interacting residues Sgd1p (S340Y ation NOM1 preribosomes stages preceding        N343Y) make direct contact CS residue Fal1p
cleavage 35S pre-rRNA transcript (consistent       (T322), gross structural rearrangement reported nucleolar localization NOM1 [Simmons           required. Detailed biochemical characterization et al. 2005] yeast ortholog, Sgd1p [Akhtar et al.      context members Sgd1p/Fal1p complex
2000]), small large ribosomal subunits    shed light mechanism fal1(T322V) cold later nuclear steps rRNA processing. Remarkably,         sensitivity extragenic suppression.
endogenous human eIF4AIII 24 proteins              Human NOM1 originally identified nucleolar
identified mass spectrometry copurifying NOM1-      eIF4A-binding protein encoded chromosome
Flag (Fig. 5C; Supplemental Fig. S6B). currently        7q36 breakpoint region majority pediatric
investigating exact composition eIF4AIII/NOM1       acute myeloid leukemia (AML) patients carrying complex.                                                       t(7;12) translocation (Simmons et al. 2005; von Bergh
   apparent difference interaction strength      et al. 2006), associated particularly poor
human NOM1 eIF4AIII relative yeast Sgd1p          prognosis. genomic segment (7q35-7q36) Fal1 similar eIF4G eIF4A       implicated critical region del(7q) leukemias (Dohner
organisms: Human eIF4G eIF4A interact            et al. 1998). Despite proximity (<1 kb) NOM1
strongly yeast counterparts (Gingras et al.         gene translocation breakpoint t(7;12)(q36;p13)
1999). difference explained lack         (Simmons et al. 2005), NOM1 mRNA levels second C-terminal eIF4A-binding region  MA3         affected (von Bergh et al. 2006). NOM1’s
domain) yeast eIF4G, yeast Sgd1p             proximity breakpoint contributes AML human NOM1 similar structures; possesses             require study. MIF4G MA3 domain (Fig. 4A; Ponting 2000;
Marintchev Wagner 2005). biochemical stud-         Materials methods
ies explain detection Sgd1p/Fal1p inter-
action yeast requires formaldehyde cross-linking,           Strains plasmids robust copurification human eIF4AIII NOM1-Flag nuclear extracts human cells occurs          Strains plasmids described Supplemental Material. cross-linking.
   CS defect fal1(T322V) strain extra-      Yeast growth
genic suppression sgd1(S340Y), synthetic     Yeast strains shown Figure 2B grown synthetic
growth defect fal1(T322V) sgd1(N343Y) double            medium lacking uracil containing 2  galactose 2 
mutant, require investigation. mutated thre-       rafinose (SGR-ura) shifted synthetic medium lacking
onine residue T322 Fal1p conserved numerous           uracil containing 2  dextrose 2  rafinose (SDR-ura).


                                                                                            GENES & DEVELOPMENT            1087
 Alexandrov et al.


Strains Figure 2C Supplemental Figure S7, B C,        proteins siRNA depletion affected rRNA biogenesis grown SGR SGR-ura media, respectively,            HeLa cells; human eIF4AIII listed proteins
shifted SGR SDR SGR-ura/SDR-ura media,              (Wild et al. 2010).
spectively.
                                                                      References
Construction isolation TS CS mutants
                                                                      Akhtar N, Pahlman AK, Larsson K, Corbett AH, Adler L. 2000.
Mutations Fal1p specific positions (149, 152, 304, 322)        SGD1 encodes essential nuclear protein Saccharomy- generated using PCR QuickChange-based methods                   ces cerevisiae affects expression GPD1 gene using DNA oligonucleotides specific degenerate (NNN)             glycerol 3-phosphate dehydrogenase. FEBS Lett 483: 87–92.
triplets. Mutations Fal1p random positions generated       Andersen CB, Ballut L, Johansen JS, Chamieh H, Nielsen KH,
using error-prone PCR using Taq polymerase elevated Mg2+.            Oliveira CL, Pedersen JS, Seraphin B, Le Hir H, Andersen GR.
Libraries resulting fal1*-HIS5 cassettes (Supplemental Fig.           2006. Structure exon junction core complex S9B) linearized transformed yeast, FAL1(WT)-           trapped DEAD-box ATPase bound RNA. Science 313:
containing plasmid counterselected, growth            1968–1972.
resulting strains assessed different temperatures.         Ballut L, Marchadier B, Baguet  Tomasetto C, Seraphin B, Le
phenotypes isolated mutants [fal1(CS), fal1(CS2), fal1(TS),       Hir H. 2005. exon junction core complex locked fal1(TS2)] confirmed tetrad analysis (Supplemental Figs.         RNA inhibition eIF4AIII ATPase activity. Nat Struct
S3D, S9E) complementation FAL1(WT) (Supplemental                Mol Biol 12: 861–869.
Figs. S3E, S9C).                                                      Bleichert F, Baserga SJ. 2007. long unwinding road RNA
                                                                         helicases. Mol Cell 27: 339–352.
                                                                      Bono F, Ebert J, Lorentzen E, Conti E. 2006. crystal
Northern blot
                                                                         structure exon junction complex reveals RNA separated formaldehyde agarose (1 ) transferred               maintains stable grip mRNA. Cell 126: 713–725. Zeta-Probe membrane (Bio-Rad), cross-linked using UV254            Budiman  Bubenik JL, Miniard AC, Middleton LM, Gerber
(Stratalinker 2400), visualized synthetic 59-end 32P-           CA, Cash  Driscoll DM. 2009. Eukaryotic initiation factor
labeled DNA oligonucleotide probes (Supplemental Fig. S2).               4a3 selenium-regulated RNA-binding protein selec-
                                                                         tively inhibits selenocysteine incorporation. Mol Cell 35:
                                                                         479–489.
Protein purification
                                                                      Corpet F. 1988. Multiple sequence alignment hierarchical
Protein purification described Supplemental Material.          clustering. Nucleic Acids Res 16: 10881–10890.
                                                                      Dohner K, Brown J, Hehmann U, Hetzel C, Stewart J, Lowther
                                                                         G, Scholl C, Frohling S, Cuneo  Tsui LC, et al. 1998.
Western blot
                                                                         Molecular cytogenetic characterization critical region Western Lightning Plus-ECL Enhanced Chemiluminescence                    bands 7q35-q36 commonly deleted malignant myeloid
Substrate PerkinElmer SuperSignal West Pico/Femto               disorders. Blood 92: 4031–4035.
Maximum Sensitivity Substrates Pierce used              Etchison D, Milburn S. 1987. Separation protein synthesis
detection.                                                               initiation factor eIF4A p220-associated cap binding
                                                                         complex activity. Mol Cell Biochem 76: 15–25.
                                                                      Fairman  Maroney PA, Wang W, Bowers HA, Gollnick P,
Mass spectrometry
                                                                         Nilsen TW, Jankowsky E. 2004. Protein displacement
Flag-eluted preparations NOM1 separated 4 –20                 DExH/D ‘RNA helicases’ duplex unwinding.
SDS PAGE stained SYPRO Ruby, gel slices                Science 304: 730–734.
analyzed ESI-LC-MS/MS Columbia University Protein               Gatfield D, Unterholzner L, Ciccarelli FD, Bork P, Izaurralde E.
Core Facility.                                                           2003. Nonsense-mediated mRNA decay Drosophila:                                                                          intersection yeast mammalian pathways.
                                                                         EMBO J 22: 3960–3970.
Software used
                                                                      Gingras AC, Raught B, Sonenberg N. 1999. eIF4 initiation
Sequences aligned using Multalin (Corpet 1988),            factors: effectors mRNA recruitment ribosomes shaded Boxshade 3.21.                                               regulators translation. Annu Rev Biochem 68: 913–963.
                                                                      Giorgi C, Yeo GW, Stone  Katz DB, Burge C, Turrigiano G,
Acknowledgments                                                          Moore MJ. 2007. EJC factor eIF4AIII modulates synap-
                                                                         tic strength neuronal protein expression. Cell 130: 179– thank Shobha Vasudevan, Nikolay Kolev, Mei-Di Shu, Sumit              191.
Borah, Abiodun Kukoyi help, valuable discussions,         Gonzalez CI, Bhattacharya  Wang W, Peltz SW. 2001. Non-
sharing reagents. thank Adrian Krainer sharing               sense-mediated mRNA decay Saccharomyces cerevisiae.
antibody human eIF4AIII, Christine Guthrie critically        Gene 274: 15–25.
reading manuscript, Angie Miccinello editorial help,      Goyer C, Altmann M, Trachsel H, Sonenberg N. 1989. Identi- rest Steitz laboratory stimulating discussions.      fication characterization cap-binding proteins work supported grant GM026154 NIH. J S              yeast. J Biol Chem 264: 7603–7610. investigator Howard Hughes Medical Institute.               Gross T, Siepmann  Sturm D, Windgassen M, Scarcelli JJ,
                                                                         Seedorf M, Cole CN, Krebber H. 2007. DEAD-box RNA
Note added proof                                                      helicase Dbp5 functions translation termination. Science
                                                                         315: 646–649. manuscript review, laboroatory Ulrike        Hinnebusch AG. 2006. eIF3: versatile scaffold translation
Kutay reported high-throughput identification 153 human             initiation complexes. Trends Biochem Sci 31: 553–562.


1088       GENES & DEVELOPMENT
                                                                                                 eIF4AIII eIF4G-like partner, NOM1


Isken O, Maquat LE. 2008. multiple lives NMD factors:          Oberer M, Marintchev  Wagner G. 2005. Structural basis    balancing roles gene genome regulation. Nat Rev                enhancement eIF4A helicase activity eIF4G. Genes
   Genet 9: 699–712.                                                     Dev 19: 2212–2223.
Kressler D, la Cruz J, Rojo M, Linder P. 1997. Fal1p         Palacios IM, Gatfield D, St Johnston D, Izaurralde E. 2004.    essential DEAD-box protein involved 40S-ribosomal-sub-             eIF4AIII-containing complex required mRNA localiza-
   unit biogenesis Saccharomyces cerevisiae. Mol Cell Biol            tion nonsense-mediated mRNA decay. Nature 427: 753–
   17: 7283–7294.                                                        757.
Lax S, Fritz W, Browning K, Ravel J. 1985. Isolation              Pendle AF, Clark GP, Boon R, Lewandowska D, Lam YW,
   characterization factors wheat germ exhibit              Andersen J, Mann M, Lamond AI, Brown JW, Shaw PJ.
   eukaryotic initiation factor 4B activity overcome                 2005. Proteomic analysis Arabidopsis nucleolus sug-
   7-methylguanosine 59-triphosphate inhibition polypeptide           gests novel nucleolar functions. Mol Biol Cell 16: 260–269.
   synthesis. Proc Natl Acad Sci 82: 330–333.                         Ponting CP. 2000. Novel eIF4G domain homologues linking
Lebaron S, Froment C, Fromont-Racine M, Rain JC, Monsarrat               mRNA translation nonsense-mediated mRNA decay.
   B, Caizergues-Ferrer M, Henry Y. 2005. splicing ATPase            Trends Biochem Sci 25: 423–426.
   prp43p component multiple preribosomal particles.          Puig O, Caspary F, Rigaut G, Rutz B, Bouveret E, Bragado-
   Mol Cell Biol 25: 9269–9282.                                          Nilsson E, Wilm M, Seraphin B. 2001. tandem affinity
Le Hir H, Izaurralde E, Maquat LE, Moore MJ. 2000a.                  purification (TAP) method: general procedure protein
   spliceosome deposits multiple proteins 20–24 nucleotides              complex purification. Methods 24: 218–229.
   upstream mRNA exon-exon junctions. EMBO J 19: 6860–             Ray BK, Lawson TG, Kramer JC, Cladaras MH, Grifo JA,
   6869.                                                                 Abramson RD, Merrick WC, Thach  1985. ATP-depen-
Le Hir H, Moore MJ, Maquat LE. 2000b. Pre-mRNA splicing                  dent unwinding messenger RNA structure eukaryotic
   alters mRNP composition: evidence stable association           initiation factors. J Biol Chem 260: 7651–7658.
   proteins exon–exon junctions. Genes Dev 14: 1098–1108.          Rigaut G, Shevchenko  Rutz B, Wilm M, Mann M, Se´raphin B.
Le Hir H, Gatfield D, Izaurralde E, Moore MJ. 2001. exon–            1999. generic protein purification method protein
   exon junction complex provides binding platform                 complex characterization proteome exploration. Nat
   factors involved mRNA export nonsense-mediated                 Biotechnol 17: 1030–1032.
   mRNA decay. EMBO J 20: 4987–4997.                                  Rocak S, Linder P. 2004. DEAD-box proteins: driving forces
Li J, Li WX. 2006. novel function Drosophila eIF4A               RNA metabolism. Nat Rev Mol Cell Biol 5: 232–
   negative regulator Dpp/BMP signalling mediates              241.
   SMAD degradation. Nat Cell Biol 8: 1407–1414.                      Rozen F, Edery  Meerovitch K, Dever TE, Merrick WC,
Li Q, Imataka H, Morino S, Rogers GW Jr, Richter-Cook NJ,                Sonenberg N. 1990. Bidirectional RNA helicase activity    Merrick WC, Sonenberg N. 1999. Eukaryotic translation                 eucaryotic translation initiation factors 4A 4F. Mol Cell
   initiation factor 4AIII (eIF4AIII) functionally distinct      Biol 10: 1134–1144.
   eIF4AI eIF4AII. Mol Cell Biol 19: 7336–7346.                   Schutz P, Bumann M, Oberholzer AE, Bieniossek C, Trachsel H,
Li  Lee  Moradi E, Hung NJ, Johnson AW, Marcotte EM. 2009.           Altmann M, Baumann U. 2008. Crystal structure    Rational extension ribosome biogenesis pathway